首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Jpad-journal of prevention of alzheimers disease

缩写:

ISSN:2274-5807

e-ISSN:2426-0266

IF/分区:7.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1145
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yuning Zhao,Guangxin Luo,Can Huang et al. Yuning Zhao et al.
Background: Given the growing global public health burden of Alzheimer's disease, this study used the Bayesian network meta-analysis to assess the effects of pharmacological and non-pharmacological interventions on cognit...
Jingyi Lin,Yiliang Liu,Ziyu Ouyang et al. Jingyi Lin et al.
Accurate modeling of biological age has clinical value for risk stratification, personalized prevention, and intervention planning, promoting proactive healthcare for aging and age-related diseases. Because aging is multidimensional, robust...
Muhammed L Sambou,Jolanda H M Dobbe,Elaine A C Albers et al. Muhammed L Sambou et al.
Background: Optimal dementia risk reduction strategies benefit from sufficient public knowledge of risk factors and risk perception, but current public awareness is uncertain. ...
Michelle Gerards,Lena Sannemann,Frank Jessen Michelle Gerards
Background: Social factors have been linked to cognitive decline and risk of dementia. However, our understanding of their impact on cognition in the context of Alzheimer's disease (AD) pathology is still limited. ...
Wai-Ying Wendy Yau,Rema Raman,Jasmeer Chhatwal et al. Wai-Ying Wendy Yau et al.
Background: The late-life "obesity paradox" of reduced Alzheimer's disease (AD) risk is postulated to be driven by underlying preclinical/prodromal pathology. However, few studies have directly examined the joint associat...
Ryosuke Shimasaki,Masanori Kurihara,Taro Bannai et al. Ryosuke Shimasaki et al.
Background: Although clinical trials have suggested a lower incidence of adverse events associated with Lecanemab in Asian populations compared to global cohorts, longitudinal real-world data across broader clinical indic...
A F Rirash,S Franzen,R Bourdage et al. A F Rirash et al.
Underrepresented populations in dementia prevention research, including minoritized racial/ethnic groups, individuals with lower socioeconomic status, and others facing social and structural disadvantages, are disproportionately affected by...
Jing Wu,Jiali Zhou,Shiyi Shan et al. Jing Wu et al.
Background: Mood disorders, particularly depressive and bipolar disorders, have emerged as potentially modifiable risk factors for dementia. However, the burden of dementia attributable to mood disorders remains unquantif...
Lena Sannemann,Michelle Gerards,Lara Bohr et al. Lena Sannemann et al.
Background: The risk for dementia is to a significant extent driven by potentially modifiable factors. Prevention strategies are increasingly aiming at individually tailored risk reduction approaches, particularly in ligh...